Correction to ‘abstracts; paper 128’

Abstract

Abstracts. Drug Alcohol Rev., 2023;42:S3–196. https://doi.org/10.1111/dar.13749

(Paper 128) The impact of imprisonment on hospitalisations with injecting-related injuries and diseases: A longitudinal cohort study.

There was an error in the dataset that generated the results for Paper 128. This error has been corrected and the findings and implications in the ‘Method’, ‘Results’, ‘Conclusion’ and ‘Implications for Policy’ sections have been updated as follows.

“Method: Data were drawn from 400 men participating in the Prison and Transition Health (PATH) study who injected drugs at least monthly prior to incarceration. Participants completed four surveys which were linked to state-wide hospital admissions and corrections data, 2014–2022. We estimated the crude incidence rate (per 1000 person-years) of hospitalisations for IRID overall and compared risk in and out of prison.

Results: Ninety-eight participants were admitted 181 times with an IRID diagnosis (13% of all hospitalisations). Most were for skin and soft tissue infections (73%) and 34% were for an invasive infection (admissions were not mutually exclusive). Overall IRID incidence rate was 59.2 (95% confidence interval [CI] 51.4–68.2) and 14.2 (95% CI 8.3–24.4) and 78.4 (95% CI 67.8–90.6) during time in and out of prison, respectively. There was a substantial reduction in risk of hospitalisation during time in prison (incidence rate ratio [IRR] 0.2; 95% CI 0.1–0.3; p < 0.001) compared to time in the community. This was similar for the risk of any invasive infections (IRR 0.1; 95% CI 0.0–0.3; p < 0.001) and skin and soft tissue infections (IRR 0.2; 95% CI 0.1–0.4; p < 0.001).

Conclusion: The incidence of hospitalisations with IRID among this cohort was high and appeared significantly elevated post-release.

Implications for Policy: These data evidence the desperate need for interventions that address injecting risk post-release.”

We apologise for this error.